Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL1300095 | 重组抗CD20单克隆抗体注射液 | Recombinant anti-CD20 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2013-12-27 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2016-12-30 | view |
CXSL1300094 | 重组抗CD20单克隆抗体注射液 | Recombinant anti-CD20 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2013-12-27 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2016-12-30 | view |